RNF128 Promotes Malignant Behaviors via EGFR/MEK/ERK Pathway in Hepatocellular Carcinoma.

Xue-Song BaiChi ZhangRui PengGuo-Qing JiangSheng-Jie JinQian WangAi-Wu Ke Dou-Sheng Bai

Published in: OncoTargets and therapy (2020)

RNF128 promotes HCC progression by activating EGFR/MEK/ERK signaling pathway, which might function as a novel prognostic molecular signature with the potential to be a candidate therapeutic target for HCC patients.

Keyphrases

signaling pathway
pi k akt
small cell lung cancer
end stage renal disease
epidermal growth factor receptor
tyrosine kinase
newly diagnosed
ejection fraction
epithelial mesenchymal transition
cell proliferation
induced apoptosis
chronic kidney disease
oxidative stress
climate change
dna repair